| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6486145 |
Meiosis regulating compounds |
Nov. 26, 2002 |
| 6482813 |
Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them |
Nov. 19, 2002 |
| 6476011 |
Methods for introducing an estrogenic compound |
Nov. 5, 2002 |
| 6468994 |
Budesonide particles and pharmaceutical compositions containing them |
Oct. 22, 2002 |
| 6465446 |
Treatment of dermatitis by the topical application of .DELTA.5-androstene-3.beta.-ol-7,17 dione and metabolizable precursors thereof |
Oct. 15, 2002 |
| 6458778 |
Estradienes |
Oct. 1, 2002 |
| 6444668 |
Combination regimens using progesterone receptor modulators |
Sep. 3, 2002 |
| 6432939 |
17a-hydroxy-4-androstene-3-one and derivatives thereof |
Aug. 13, 2002 |
| 6432938 |
19-nor-cholane steroids as neurochemical initators of change in human hypothalamic function |
Aug. 13, 2002 |
| 6432439 |
O/W emulsion composition |
Aug. 13, 2002 |
| 6423701 |
Water soluble amine esters of testosterone for intranasal administration |
Jul. 23, 2002 |
| 6423698 |
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
Jul. 23, 2002 |
| 6417179 |
Ear wax solution |
Jul. 9, 2002 |
| 6407084 |
Cosmetic or dermatological use of 7-hydroxylated steroids |
Jun. 18, 2002 |
| 6399085 |
Method of moisturizing the skin by the topical application of .DELTA.5-androstene-3.beta.-ol-7,17 dione and metabolizable precursors thereof |
Jun. 4, 2002 |
| 6399084 |
Method for diminishing wrinkles and fine lines of the skin by the topical application of .DELTA.5-androstene-3.beta.-ol-7, 17 dione and metabolizable precursors thereof |
Jun. 4, 2002 |
| 6372732 |
Use of delta5-androstene-3beta-ol-7, 17-dione in the treatment of lupus erythematosus |
Apr. 16, 2002 |
| 6369115 |
Stabilized powder formulations |
Apr. 9, 2002 |
| 6365580 |
Process for the production of difluoromethane |
Apr. 2, 2002 |
| 6355630 |
Estra-1,3,5(10)-triene-7.alpha.-thioethers |
Mar. 12, 2002 |
| 6352722 |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
Mar. 5, 2002 |
| 6352980 |
Estrenes for inducting hypothalamic effects |
Mar. 5, 2002 |
| 6346523 |
Budesonide particles and pharmaceutical compositions containing them |
Feb. 12, 2002 |
| 6333317 |
Regulation of amyloid precursor protein (APP) expression by administration of an estrogenic compound |
Dec. 25, 2001 |
| 6313108 |
Orally active androgens |
Nov. 6, 2001 |
| 6313180 |
Steroid compounds having contraceptive and anti-osteoporosis activity |
Nov. 6, 2001 |
| 6306846 |
Anti-inflammatory and anti-ulcer compounds and process |
Oct. 23, 2001 |
| 6297228 |
Use of angiostatic steroids in photodynamic therapy |
Oct. 2, 2001 |
| 6288049 |
Fluorometholone ophthalmic suspension |
Sep. 11, 2001 |
| 6284750 |
.alpha.-hydroxyacid esters of DHEA useful against skin disorders |
Sep. 4, 2001 |
| 6274582 |
Preparation for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
Aug. 14, 2001 |
| 6271220 |
Anti-angiogenic agents |
Aug. 7, 2001 |
| 6271221 |
Use of equilenin as an antioxidant |
Aug. 7, 2001 |
| 6268356 |
Flocculated suspension of megestrol acetate |
Jul. 31, 2001 |
| 6265393 |
Prevention of endometriosis signs or symptons |
Jul. 24, 2001 |
| 6251956 |
Combination progestin oral contraceptive regimen |
Jun. 26, 2001 |
| 6248352 |
Compositions containing lipid compounds derived from sphingoid bases, their process of preparation |
Jun. 19, 2001 |
| 6245756 |
Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system |
Jun. 12, 2001 |
| 6242436 |
Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans |
Jun. 5, 2001 |
| 6228850 |
Antiangiogenic activity of betulinic acid and its derivatives |
May. 8, 2001 |
| 6228852 |
Transdermal application of naturally occurring steroid hormones |
May. 8, 2001 |
| 6225299 |
Hormonal agent for skin treatment |
May. 1, 2001 |
| 6225297 |
Combination contraceptive |
May. 1, 2001 |
| 6221857 |
Altering sex ratio of offspring in mammals |
Apr. 24, 2001 |
| 6218435 |
Reduction of hair growth |
Apr. 17, 2001 |
| RE37116 |
Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
Mar. 27, 2001 |
| 6204258 |
Method of treating alopecia |
Mar. 20, 2001 |
| 6200966 |
Compositions for inhibiting airway wall inflammation |
Mar. 13, 2001 |
| 6197762 |
Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
Mar. 6, 2001 |
| 6194393 |
Solution and solid-phase formation of glycosidic linkages |
Feb. 27, 2001 |
|
|
|
